This CEO wants to cover weight loss drugs for employees. They’re just too expensive.

For Dr. Joseph Cacchione, the math on GLP-1 drugs stopped making sense. Subscribe to read this story ad-free Get unlimited access to ad-free articles and exclusive content. The CEO of the Philadelphia-based nonprofit hospital system Jefferson said his organization now spends more on prescription drug coverage — fueled by the soaring use of weight loss … Read more

FDA asks Lilly for more safety data on weight loss pill Foundayo

The Food and Drug Administration is asking Eli Lilly to gather more safety data on its new weight loss pill, Foundayo, including whether it could be linked to liver and heart problems, according to the approval letter published online Tuesday. Subscribe to read this story ad-free Get unlimited access to ad-free articles and exclusive content. … Read more

New weight loss drug to be sold on Trump’s pharmaceutical cost comparison platform

A first-of-its-kind weight loss pill will become the latest drug to be offered on President Trump’s cost comparison platform “Trump Rx,” CBS News exclusively learned.  Foundayo, a GLP-1 drug, is a first-of-its-kind weight loss pill that doesn’t need to be taken on an empty stomach, expanding access for those who are needle averse.  A White … Read more

What to know about the new weight loss pill approved by the FDA

The FDA has approved a pill from Eli Lilly that could change how millions of Americans take medications to lose weight. The drug is the second GLP-1 pill approved by federal regulators for weight loss and the first that doesn’t require fasting or meal timing. Dr. Celine Gounder breaks down what to know about accessibility … Read more

FDA approves GLP-1 weight loss pill Foundayo from Eli Lilly

The Food and Drug Administration on Wednesday approved a new weight loss pill from drugmaker Eli Lilly. Subscribe to read this story ad-free Get unlimited access to ad-free articles and exclusive content. The daily pill, called Foundayo, is the second oral GLP-1 to reach the market in recent months, following the approval of Novo Nordisk’s … Read more

Tafoya rips Walz ‘dodging’ accountability in hearing, unveils plan to fight fraud: ‘Full weight of the law’

NEWYou can now listen to Fox News articles! EXCLUSIVE: Minnesota Republican Senate candidate Michele Tafoya slammed Gov. Tim Walz’s testimony on the massive fraud scandal roiling Minnesota during a contentious House hearing on Wednesday and outlined her plan to combat fraud, which she says voters have been clamoring about on the campaign trial.  House Oversight … Read more